Jupiter Neurosciences, Inc. (JUNS)
3.06
-0.03
(-0.97%)
USD |
NASDAQ |
Sep 10, 16:00
3.08
+0.02
(+0.65%)
After-Hours: 20:00
Jupiter Neurosciences Shareholders Equity (Quarterly) : -0.366M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.366M |
| March 31, 2026 | -2.784M |
| December 31, 2025 | -1.832M |
| September 30, 2025 | 0.0574M |
| June 30, 2025 | 1.340M |
| March 31, 2025 | 3.065M |
| December 31, 2024 | 4.172M |
| September 30, 2024 | -5.676M |
| June 30, 2024 | -5.28M |
| March 31, 2024 | -6.020M |
| Date | Value |
|---|---|
| December 31, 2023 | -5.801M |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -7.144M |
| September 30, 2022 | -5.960M |
| June 30, 2022 | -6.198M |
| March 31, 2022 | -5.819M |
| December 31, 2021 | -5.178M |
| September 30, 2021 | -3.792M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Jaguar Health, Inc. | 6.615M |
| Atai Beckley, Inc. | 176.37M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.719M |
| Total Liabilities (Quarterly) | 4.085M |
| Debt to Equity Ratio | -4.852 |
| Current Ratio | 0.657 |
| Net Debt Paydown Yield | -2.94% |